Extend Biosciences

About:

Extend Biosciences is an emerging biotechnology company developing a novel drug delivery platform technology.

Website: http://extendbio.com/

Twitter/X: extendbio

Top Investors: National Science Foundation, MassVentures, MassChallenge

Description:

Extend Biosciences Inc. is an emerging biotechnology company developing a novel drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins. Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value. Their proprietary platform technology significantly improves the circulating half-life and bioavailability of peptides and proteins, enabling the scientific community to truly develop potent and specific drugs. Their mission is to revolutionize drug delivery and give patients a better quality of life.

Total Funding Amount:

$1.36M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)extendbio.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-06-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai